Curriculum Vitae for Barry A. Hendin, M.D.

Education:

A.B. 1964 - Washington University
M.D. 1968 - Washington University Medical School

Clinical Appointments:

Intern, St. Louis Jewish Hospital, 1968-1969
Resident & Fellow, Barnes Hospital, 1969-1972 (including rotating chief residency)
Acting Chief of Neurology Service, St. Louis City Hospital, 1972
Chief of Neurology Service, Wright-Patterson, AFB, 1972-1974
Chief of Neurology, Good Samaritan Hospital, 1979-Present
Co-Director, EEG Laboratory, Good Samaritan Hospital, 1979-present
Co-Director, EEG Laboratory, Phoenix Baptist Hospital, 1976-1991
Co-Director, EEG Laboratory, Columbia Medical Center, 1993-1999
Chairman, Division of Neurosciences, Good Samaritan Hospital, 1991-1992
Chairman, Credentials Committee, Good Samaritan Hospital, 1993-1995
Chairman, Advisory Committee, Good Samaritan Hospital, 1993-1995
Vice Chief of Staff, Good Samaritan Hospital, 1993-1995
Executive Committee, Good Samaritan Hospital, 1993-present

Academic Appointments:

Assistant (Medicine), Washington University Medical School, 1968-1969
Assistant (Neurology), Washington University Medical School, 1969-1972
Instructor (Neurology), Washington University Medical School, 1972
Clinical Associate (Neurology), University of Arizona Medical School, 1985-1987
Clinical Lecturer (Neurology), University of Arizona Medical School, 1988-1995
Consultant/Lecturer, Chigasaki Tokushukai Medical Center, Japan, November 1990
Clinical Professor of Neurology, University of Arizona Medical School, 1995-present

Other Appointments

Governor’s Council on Spinal and Head Injury, 1993-1995
Member, Board of Directors, Samaritan Health Services, 1995-1999

Chairman, Science & Technology Committee

Audit Committee
Finance Committee
Development Committee
Governance Committee
Executive Committee

Member, Board of Directors Banner Health System, 1999-

Executive Committee 1999 -2006; 2007 -
Human Resources Committee 1999 - 2001
Strategic Planning Committee 1999 - 2001
Clinical Quality & Innovation Committee 1999
Vice Chairman 2001-
` Corporate Strategy Committee, Chairman 2006 -2007
Nominating Committee
Board Vice Chairman 2007-

American Heart Association, Phoenix Board Member, 2000
Arizona Commission on Medical Education & Research, Task Force Member 2006 -

Licensure:

Missouri, 1968 (inactive) Arizona, 1974 (License #8398)

Honors and Awards:

Co-Editor, Neurologic Section, Arizona Medicine, 1975-1983
Outstanding Teacher Award, USAF Medical Center, Wright Patterson 1972-1973
Teacher of the Year Award, Good Samaritan Hospital, 1978-1979
Teacher of the Year Award, Good Samaritan Hospital, 1985-1986
Teacher of the Year Award, Good Samaritan Hospital, 1987-1988
Attending Physician of the Year Award, Barrow Neurological Institute, 1983-1984
Dean’s List for Excellence in Teaching in the Clinical Sciences, University of AZ, 1999
Dean's List for Excellence in Teaching in the Clinical Sciences, University of AZ, 2001
National Multiple Sclerosis Society – AZ Chapter Health Professional of the Year 2007
Recognition of Excellence in Teaching the Clinical Sciences, University of Arizona, 2007
Honorary Alumnus Award, University of Arizona

Society Memberships:

American Academy of Neurology, Fellow Member
Education Committee/Annual Meeting Subcommittee 1990-1997
National MS Society
Clinical Advisory Committee 2003 -
Board of Directors 2007 -
Maricopa County Medical Society
Royal Society of Medicine
Arizona Medical Association
Arizona Neurological Society
Board of Directors 2005-2007

Military Service:

Major, USAF, MC - Active Duty, September 1972 - September 1974
Chief, Neurology Service, USAF Medical Center, Wright-Patterson

Board Certification:

Neurology - American Board of Psychiatry & Neurology - March 15, 1975
Board Examiner, American Board of Psychiatry & Neurology, 1975-present

Publications:

1. Hahn TJ, Haddad JG, Hendin BA. Effect of chronic anticonvulsant therapy on serum 25-OH vitamin D levels. Clinical Research 1972; 20:238
2. Hahn TJ, Hendin BA, Shoop CR, Haddad CG. Effect of anticonvulsant therapy
on serum 25-Hydroxycholecalciferol in adults. New Eng Jour of Med 1972;
297:900-904
3. Hendin BA, DeVivo DC, Torac R, Lell M, Regab AH, Vieggi TJ. CNS parenchymatous degeneration in childhood leukemia. Presented at the American Society of Clinical Oncology, April 1972
4. Hendin BA, Hahn TJ, Haddad JG. Effect of anticonvulsant therapy on anticonvulsant vitamin D levels. Presented at the Society of ir Force Physicians, February 1973
5. Hendin BA, DeVivo DC, Torac R, Lell ME, Regab AH, Vietti TJ. Parenchymous degeneration of the central nervous system in childhood leukemia. Cancer 1974; 33:468-482
6. Trotter JL, Hendin BA, Osterland CK. Cerebellar degeneration with Hodgkin’s disease - an immunological study. Arch of Neurol 1976; 33:616-661
7. Hendin BA. The remote effects of cancer on the nervous system: cerebellar degeneration. AZ Med 1977; 34:462-463
8. Hahn TJ, Hendin BA, Haddad JG. Serum 25-Hydroxycholecalciferol levels and bone mass in children on clinical anticonvulsant therapy. New Eng Jour of Med 1975; 272:550-554
9. Hendin BA, Schaffert A. Tetanus. Samaritan Medicine. 1984; 29-32
10. Hendin BA. CPC: Herpes zoster. Samaritan Medicine 1985; 2:19
11. Yudell A, Hendin BA, Tamm HS, Guidry J. Coccidioidal meningitis narcotic amphotericin B therapy. Arch Internal Med 1988; 148:985-986
12. Clark W, Coull B, Hendin BA, et al. Randomized trial of Cervene a kappa receptor-selective opioid antagonist, in acute ischemic stroke (poster). Presented at American Academy of Neurology Meeting, Seattle, Washington, 1995
13. Clark W, Coull B, Hendin BA, et al. Randomized trial of Cervene, a kappa receptor-selective opioid antagonist, in acute ischemic stroke. Journal of Stroke and Cerebrovascular Disease; Vol 6, No. 1:35-40, 1996

Major Presentations:

American College of Physicians. Management of Cerbrovascular Disease, November 1984
American College of Physicians. Management of Cerebrovascular Disease, November 1985
American College of Physicians. Management of Cerebrovascular Disease, November 1986
Arizona Medical Association. Prevention of Cerebrovascular Disease, June 1987
American College of Physicians. Management of Cerebrovascular Disease, November 1988
Arizona Academy of Family Physicians. Management of Cerebrovascular Disease, Current Management of Epilepsy, June 1989
American College of Physicians. Management of Cerebrovascular Disease, November 1989
American College of Physicians. Management of Cerebrovascular Disease, November, 1990
American College of Physicians. Management of Cerebrovascular Disease, November 1991
American College of Physicians. Recent Advances in Therapeutics, November 1992
American College of Physicians. Recent Advances in Therapeutics, November 1993
American College of Physicians. Recent Advances in Therapeutics, November 1994
American College of Physicians. Recent Advances in Therapeutics, November 1995
American College of Physicians. Recent Advances in Therapeutics, November 1997
American College of Physicians. Recent Advances in Therapeutics, November 1998
American College of Physicians. Management of Stroke and Cerebrovascular Disease, November 1999
American College of Physicians. Brain Attack, November 2000
American College of Physicians. Stroke Update. November 2001
American College of Physicians. Stroke Therapy 2002. Mayo Clinic Scottsdale, October 2002
American College of Physicians. Neurology for the Internist. Update in Clinical Medicine. Scottsdale, AZ, November 7, 2002
American College of Physicians. Neurology Update. Scottsdale, Arizona, November 14, 2003
Instituto Nacional de Neurologia y Neurocirugia. Le Cefalia (cephalgia), Mexico City, July 1993
Kings County Family Practice Society. Recent Advances in Stroke Therapy, April 1994
San Diego Neurologic Society. New Antiepileptic Medications, May 1994
Stroke Update 1994, St. Joseph’s Hospital. Acute Stroke Treatment - New Trials and Principles, September 1994
Instituto Nacional de Neurologia y Neurocirugia. El Diagnostico y Tratmiento de la Cefalea en el Primer Nivel de Atencion. La Emfermidad Cerebro Vascular en el Primer Nivel De Atencion, Mexico City, July 1995
Third Annual Neuosciences Symposium, Good Samaritan Regional Medical Center (Phoenix, AZ). Current Medical Advances in Neurological Diseases, June 1998
Mayo Clinic Scottsdale Neuro Grand Rounds. Current Advances in Neurologic Diseases, June 10, 1998
Management of Epilepsy: Consensus Conference on Current Clinical Practice (participant), June 17, 1998, Huatulco, Mexico. Published in Supplement 4 to Neurology, Volume 51, No 5, November 1998
Neurology Grand Rounds, University of New Mexico, Albuquerque, New Mexico. June 10, 1999
American Heart Association. Clinical Management and Protocols for Stoke Patients. Phoenix, AZ, September 10, 1999
Treatment of Psychiatric and Neurologic Disorders Symposium. The Pathophysiology and Treatment of Neuropathic Pain Transmission. San Diego, CA, February 5, 2000
San Diego Academy of Family Physicians. Epilepsy. San Diego, CA, July 8, 2000
Neurology & Neurosurgery Grand Rounds, University of Arizona Health Sciences Center, Tucson, Arizona. Strategy in Headache Management. September 29, 2000
Neurology Grand Rounds, University of California, Irvine. Rational Sequencing of Antiepileptc Drugs 2003.
Nevada Academy of Family Physicians. Migraines. Reno, Nevada, May 1, 2003
Texas Academy of Family Physicians Migraine Symposium. Management of Migraine Headache. Austin, TX, October 18, 2003.
Nevada Academy of Family Physicians. Migraine, Every Minute Counts. Lake Tahoe, Nevada, February 2, 2005
Arizona Academy of Family Physicians. Migraine Update. March 2005
Update in Clinical Medicine. New Britain General Hospital. Update in Stroke/Cerebrovascular Disease. Scottsdale, Arizona, November 9, 2005
Mayo Clinic College of Medicine. 19th Annual Epilepsy Update. Scottsdale, Arizona, November 3, 2006

Research Protocols:

Principal Investigator for the following:
Protocol #E301. DHE-45 Nasal Spray for headache
Protocol #GHBA-903. Sumatriptan for headache
Protocol #IX-101-002. IV Nalmafene for stroke
Protocol #303. Mentane HP 029 for Alzheimer’s disease
Protocol #945-090. Gabapentin for epileptic seizures
Protocol #979-7. C1979 for Alzheimer’s disease
Protocol #VGPR0098. Sabril for epileptic seizures
Protocol #VGPR0101. Sabril for epileptic seizures
Protocol #LUB-IN-9. Lubeluzole for stroke
Protocol #IX-103-002. Nalmefene for stroke
Protocol #BMS 180048. CN115-025 for migraine
Protocol #M92-825. Tiagabine for seizures
Protocol #GHBA. Eldepryl for Parkinson’s disease
Protocol #S2WA-3001. Naratriptan for migraine
Protocol #IX-104-002. Nalmefene for stroke
Protocol #982-25-045. Fosphenytoin for stroke
Protocol #SB202026. 20206 for Alzheimer’s disease
Protocol #945-000-213. Neurontin for seizures
Protocol #945-217. Neurontin for migraine
Protocol #SB220453. 220453 for migraine
Protocol #105-133. Lamictal for seizures
Protocol #Lub-USA-6. Lubeluzole for stroke
Protocol #3062K1-200-US. Fiblast for stroke
Protocol #52WA4002. Naratriptan for migraine
Protocol #202026/050 for Alzheimer’s disease
Protocol #1008-099/010. Pregabalin for seizures
Protocol #CN123-011. IV BMS 204352 for stroke
Protocol #IP302-016. Citocoline for stroke
Protocol #1008-032/033. Pregabalin for low back pain
Protocol #981-124 Atorvastatin for stroke/TIA
Protocol #AST02. ICOS HALT for stroke
Protocol #30006. Lamictal comparison/menstrual abnormalities
Protocol #0101. Rufinamide for seizures
Protocol #PRI-TOP-IN-28. Topamax for seizures
Protocol #ELET-071. Eletriptan for migraine
Protocol #GLY-30011. GAIN-ASIST for stroke
Protocol #LAM40091. Lamictal for seizures
Protocol #S2W40027. Naratriptan for menstrual migraine
Protocol #872CL003. ARTIST MRI for stoke
Protocol #872CL004. ARTIST + for stroke
Protocol #CCM9981A04. Comtan for Parkinson's disease
Protocol #BMS IM101-200 for multiple sclerosis
Protocol #Biogen C1802 for multiple sclerosis
Protocol #Astra Zeneca 311CVS/0022. Zomig Nasal Spray
Protocol #SUM40299. Imitrex for migraine headaches
Protocol #Charisma EFC4505. Plavix vs aspirin
Protocol #Fujisawa FK 506 for stroke.
Protocol #XRP4563H/4001. Lovenox for stroke
Protocol #GSK 249417 for stroke
Protocol #GSK LAM40112. Lamictal for cognition
Protocol #GSK LAM40124. Lamictal for behavior
Protocol #Ilex-Campath for MS
Protocol #Berlex/MDS - MS study
Protocol #Biogen 1808 for multiple sclerosis
Protocol #Genentech. Rituxan for dermatomyositis
Protocol #ACT. Avonex/steroids for multiple sclerosis
Protocol #TEVA 9013 for MS
Protocol #Teva NC100 for MS
Protocol #Pfizer. Implement study for MS
Protocol #Genentech U2787g for MS
Protocol #Glaxo 101468/228 for Parkinson’s disease
Protocol #Glaxo LAM100034 for partial seizure
Protocol #Glaxo LAM100036 for generalized seizure
Protocol #Ortho McNeil CAPSS272 for seizure
Protocol #Biogen. Avonex for CIDP
Protocol #Glaxo 49653/461 for Alzheimer’s
Protocol #Johnson & Johnson 333369EPY2003 for seizure
Protocol #Genentech - RIM study for dermatomyositis
Protocol #Boehringer-Ingelheim - PROFESS for post-stroke
Protocol #Teva. TNC GA MS 2004 01 ASSERT for MS
Protocol # Columbia University Selection for ALS
Protocol #T-GEN for ALS
Protocol #Teva PM028. NABS for MS
Protocol #Weintraub. Palm Mag Device for Diabetic Neuropathy
Protocol #Biogen. Strata for MS
Protocol #Lilly HMDY for diabetic neuropathy
Protocol #Lilly F1J-US-HMEZ for diabetic neuropathy
Protocol #GSK AVA104617 for Alzheimer’s disease
Protocol #Novartis FTY720D 2302 for MS
Protocol #Biogen 101MS 102 for MS
Protocol #Biogen 109 MS 301 for MS
Protocol #Lilly. Small fiber neuropathy
Protocol #BIOMS MBP8298-SP--03 for secondary progressive MS
Protocol # Biogen 101MS 402 for MS
Protocol #Teva Bravo for MS
Protocol #Lilly HMEF for MS
Protocol #Merck Musi Qo1 for MS
Protocol #Roche/Genentech olcrizimab for MS
Protocol #Medimmune CP 151 for dermatomyositis/polymyositis
Protocol #David Saperstein. Lithium for inclusion body myositis
Protocol #Cytex. Arimoclomol for ALS
Protocol #Mass General. Ceftriaxone for ALS
Protocol #T-GEN. Tretinoin for ALS
Protocol #Schering-Plough TIMI 50 for post-stroke
Protocol #Genzyme MTAP. Myozyme for Pompe
Protocol #J&J 333369 NPP 2002 for diabetic peripheral neuropathy